TipRanks
Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
Germany Market
XRP2
Silence Therapeutics
RESEARCH TOOLSreports

Silence Therapeutics (XRP2) Income Statement

37 Followers

Silence Therapeutics Income Statement

Last quarter (Q2 2026), Silence Therapeutics's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q2, Silence Therapeutics's net income was £-12.29M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 559.00K£ 43.26M£ 25.38M£ 17.65M£ 12.41M
Gross Profit
$ 344.00K£ 31.45M£ 15.06M£ 6.68M£ 4.96M
Operating Expenses
$ 90.10M£ 94.77M£ 64.66M£ 56.44M£ 50.77M
Depreciation and Amortization
$ 555.00K£ 463.32K£ 498.00K£ 490.91K-
EBITDA
$ -88.05M£ -49.12M£ -49.78M£ -39.93M-
Operating Income
$ -89.75M£ -63.32M£ -49.60M£ -49.76M£ -45.81M
Other Income/Expenses
$ 1.15M£ 18.86M£ -706.00K£ 9.29M£ -42.00K
Pretax Income
$ -88.60M£ -44.46M£ -50.31M£ -40.47M£ -45.86M
Net Income
$ -88.61M£ -45.31M£ -43.27M£ -41.03M£ -39.41M
Per Share Metrics
Basic EPS
$ -5.67£ -2.37£ -3.48£ -3.78£ -1.35
Diluted EPS
$ -5.67£ -2.37£ -3.48£ -3.78£ -1.35
Weighted Average Shares Outstanding
 15.74M 15.42M 12.36M 10.73M 29.65M
Weighted Average Shares Outstanding (Diluted)
 15.74M 15.42M 12.36M 10.73M 29.65M

Silence Therapeutics Earnings and Revenue History